REPL
Replimune Group, Inc.NASDAQStock$8.88+0.26 (+2.96%)Mkt Cap 732.8MP/E —Div Yield —Beta 0.91Vol 1.6MAvg Vol 7.8M
52W$1.70
$12.63
ETFs That Hold REPL (Replimune Group, Inc.)
1M
+70.11%
3M
+20.65%
6M
-7.60%
YTD
-0.22%
1Y
-9.66%
3Y
-63.03%
5Y
-74.30%
ETFs That Hold REPL
Replimune Group, Inc. is held by 49 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
Excludes leveraged and inverse ETFs.
PreviousPage 3 of 3
Frequently Asked Questions
How many ETFs hold REPL?
Replimune Group, Inc. (REPL) is held by 49 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds REPL?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $8.11B in AUM holds 0.26% of its portfolio in REPL, representing $21.4M in market value.
What percentage of CNCR is REPL?
REPL makes up 3.54% of CNCR (Loncar Cancer Immunotherapy ETF), making it one of the largest positions in that fund.
Is REPL in the S&P 500?
REPL is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.